Case Report: Tocilizumab for Acute Kidney Graft Dysfunction in Patient Affected by COVID-19
Medicine
[키워드] acute kidney
Acute kidney injury
acute respiratory syndrome
adopted
affected
cause
characterized
contributing to
coronavirus
coronavirus disease
COVID-19
Critical
cytokine
Cytokine release syndrome
develop
dysfunction
elevated
Graft
graft dysfunction
higher risk
humanized monoclonal antibody
Hyperactivation
IL-6
immune
immune system
Immunosuppression
Infection
Inflammatory response
interleukin-6
kidney
kidney transplant
management
morbidity and mortality
pandemic
Patient
receptor
recipient
rejection
rheumatoid arthritis
SARS-CoV-2
SARS-COV-2 infection
solid organ
systemic inflammation
the WHO
therapy
Tocilizumab
tocilizumab administration
transplantation
[DOI] 10.3389/fmed.2021.732792 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.732792 PMC 바로가기 [Article Type] Medicine